Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
CAMK2N2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
GTF2IP20 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
SRCAP - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CCND2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RDH10 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MBD4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ODF3B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC100130987 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ANHX - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZNF397 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TRIO - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SART3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC401317 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TBC1D7 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
INPP5K - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on